Vyome Holdings (HIND) Minority Interest (2024 - 2026)

Vyome Holdings (HIND) posted quarterly Minority Interest of $1.3 million for Q1 2026, down 1.71% quarter-over-quarter from $1.3 million in Q4 2025.

Vyome Holdings (HIND) Minority Interest (2024 - 2026) Analysis & Trends

Vyome Holdings' Minority Interest history runs 3 years deep, the most recent figure standing at $1.3 million for Q1 2026.

In Q1 2026, Minority Interest changed N/A year-over-year to $1.3 million; the TTM figure through Mar 2026 stood at $1.3 million (changed N/A YoY), while the FY2025 annual figure was $1.3 million, up 131995700.0% from the prior year.
Minority Interest for Q1 2026 stood at $1.3 million, down from $1.3 million in the prior quarter.
The five-year high for Minority Interest was $1.4 million in Q3 2025, with the low at $1.0 in Q4 2024.
The 3-year median for Minority Interest is $1.3 million (2025), against an average of $1.0 million.
Peak annual rise in Minority Interest reached 131995700.0% in 2025, while the deepest fall reached 131995700.0% in 2025.
Vyome Holdings' Minority Interest stood at $1.0 in 2024, then soared by 131995700.0% to $1.3 million in 2025, then declined by 1.71% to $1.3 million in 2026.
Business Quant data shows HIND's Minority Interest at $1.3 million in Q1 2026, $1.3 million in Q4 2025, and $1.4 million in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	138.65 Bn	130.80 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	85.93 Bn	77.94 Bn	3.93 Bn
3	Argenx Se	64.84 Bn	59.66 Bn	1.37 Bn
4	Moderna	57.38 Bn	52.25 Bn	52.00 Mn
5	BeOne Medicines	41.94 Bn	36.84 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	31.54 Bn	28.23 Bn	992.69 Mn
7	BioNTech SE	27.72 Bn	9.33 Bn	668.28 Mn
8	Insmed	27.49 Bn	26.33 Bn	358.27 Mn
9	Royalty Pharma	27.33 Bn	26.49 Bn	-
10	Vyome Holdings	16.04 Mn	8.15 Mn	11,658.00

Download Data